|
| | Pitavastatin Impurity 13 Basic information |
| Product Name: | Pitavastatin Impurity 13 | | Synonyms: | Pitavastatin Impurity 13;Pivastatin impurity 13;(3R,5S)-5-(6-Cyclopropyl-10-fluoro-7,8-dihydrobenzo[k]phenanthridin-8-yl)-3,5-dihydroxypentanoic acid sodium salt | | CAS: | | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File |  |
| | Pitavastatin Impurity 13 Chemical Properties |
| Melting point | >182°C (dec.) | | storage temp. | Hygroscopic, -20°C Freezer, Under inert atmosphere | | solubility | DMSO, Water | | form | Solid | | color | Pale Yellow |
| | Pitavastatin Impurity 13 Usage And Synthesis |
| Uses | (3R,5S)-5-(6-Cyclopropyl-10-fluoro-7,8-dihydrobenzo[k]phenanthridin-8-yl)-3,5-dihydroxypentanoic Acid Sodium Salt is an impurity of Pitavastatin (P531000), a competitive inhibitor of HMG-CoA reductase. Antilipemic. |
| | Pitavastatin Impurity 13 Preparation Products And Raw materials |
|
